Skip to main content
Walvax Biotechnology Co.,Ltd. logo

Walvax Biotechnology Co.,Ltd. — Investor Relations & Filings

Ticker · 300142 ISIN · CNE100000WN2 LEI · 300300H82R2DIQXA8N24 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,790 across all filing types
Latest filing 2020-04-17 Major Shareholding Noti…
Country CN China
Listing Shenzhen Stock Exchange 300142

About Walvax Biotechnology Co.,Ltd.

https://www.walvax.com

Walvax Biotechnology Co.,Ltd. is a biopharmaceutical enterprise specializing in the research, development, production, and distribution of vaccines and other biological products. The company focuses on modern biotechnology to address public health challenges through a diverse portfolio of preventive vaccines. Key products include the 13-valent pneumococcal polysaccharide conjugate vaccine (PCV13), the bivalent human papillomavirus (HPV) vaccine, and various combination vaccines for meningitis and Haemophilus influenzae type b (Hib). Walvax operates advanced R&D platforms and manufacturing facilities that comply with international quality standards. The company is actively involved in the development of next-generation vaccine technologies, including mRNA and recombinant protein platforms, aiming to provide affordable and high-quality immunization solutions for global markets.

Recent filings

Filing Released Lang Actions
关于股东股份质押的公告
Major Shareholding Notification Classification · 100% confidence The document is a public announcement from a company regarding the pledge of shares by a significant shareholder. It details the number of shares pledged, the pledge period, the pledgee, and the proportion of shares pledged relative to total holdings. It includes no financial statements, no management discussion, no earnings data, and no regulatory certifications. The content fits the description of a Major Shareholding Notification, as it informs about changes in significant share ownership levels or encumbrances such as pledges. The document length is short and focused solely on share pledge information, not a full report or announcement of a report publication. Therefore, the appropriate classification is Major Shareholding Notification (MRQ).
2020-04-17 Chinese
关于股东减持股份计划实施进展暨减持数量过半的公告
Transaction in Own Shares Classification · 95% confidence The document is an announcement regarding the progress of a shareholder's plan to reduce their shareholding in the company. It details the number of shares sold, dates, prices, and the impact on ownership percentages. It references compliance with relevant regulations on shareholding reductions and confirms that the shareholder is not a controlling party. The document does not contain financial statements or detailed financial performance data, nor is it a report or presentation. It is a notification about a transaction in the company's own shares by a significant shareholder. Therefore, it fits the category of 'Transaction in Own Shares' (POS). The document length is short and focused on share reduction progress, not a full report or regulatory filing.
2020-04-16 Chinese
关于股东股份质押的公告
Capital/Financing Update Classification · 95% confidence The document is a public announcement from a company regarding the pledge of shares by a significant shareholder. It details the number of shares pledged, the pledge period, the pledgee, and the proportion of shares pledged relative to total and held shares. It also references related documents such as the stock pledge repurchase agreement and shareholder holding change details. There is no financial report, earnings data, or management discussion. The content fits the category of a notification about share pledging, which is a capital structure-related update. Therefore, the document is best classified as a Capital/Financing Update (CAP). The document length is short and focused on a specific financing event, not a full report or announcement of a report publication.
2020-04-15 Chinese
2019年年度股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a detailed announcement of the resolutions passed at the 2019 Annual General Meeting (AGM) of Yunnan Watson Biotechnology Co., Ltd. It includes voting results on various agenda items such as the 2019 board work report, supervisory board report, audited financial report, profit distribution plan, and appointment of auditors. The document also mentions the meeting date, attendance, voting methods, and legal opinions confirming the validity of the meeting and voting process. The content is focused on the official results and decisions made at the AGM rather than the full annual report or financial statements themselves. The document length is 4427 characters, which is relatively short and consistent with an announcement of voting results rather than the full report. Therefore, the document fits best into the category of Declaration of Voting Results & Voting Rights Announcements (DVA).
2020-04-13 Chinese
关于对深圳证券交易所创业板年报问询函【2020】第20号的回复
Annual Report Classification · 95% confidence The document is a detailed response from a company (云南沃森生物技术股份有限公司) to an inquiry letter from the Shenzhen Stock Exchange regarding its annual report for the year 2019. It contains extensive financial data, explanations of revenue, inventory, accounting policy changes, and bad debt provisions related to the annual reporting period. The document is substantive, with detailed financial analysis and explanations, indicating it is part of the annual report or a detailed response related to it. There is no indication that this is merely an announcement or a short notice. The content aligns with the characteristics of an Annual Report (10-K) or a detailed regulatory response related to the annual report. Given the context and length, the best fit is Annual Report (10-K). FY 2019
2020-04-13 Chinese
2019年年度股东大会的法律意见书
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a legal opinion letter from a law firm regarding the 2019 Annual General Meeting (AGM) of Yunnan Watson Biotechnology Co., Ltd. It details the procedures of the AGM, including the convening, attendance, voting procedures, and the results of the shareholder votes on various agenda items such as the 2019 annual reports and profit distribution plan. The document does not contain the actual annual report or financial statements but rather confirms the legality and validity of the AGM process and voting results. This type of document is typically classified as a Declaration of Voting Results & Voting Rights Announcements (DVA), as it officially reports the outcomes of shareholder votes at the AGM.
2020-04-13 Chinese

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.